An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.
Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.
One of Australia’s largest debt collectors, ACM Group, harassed and coerced vulnerable customers — including a stroke victim — by bombarding them with phone calls and making empty threats of litigation, the Federal Court found Monday.
The first personal fine against a union official has been handed down in the wake of the High Court’s ruling that courts can order union officials to pay out of their own pockets for violating the Fair Work Act.
A judge overseeing a securities class action against former directors of failed pharmaceutical company QRxPharma and its legal advisor DibbsBarker has ruled that certain documents, including numerous emails sent by the law firm, are protected by attorney-client privilege.
Bunnings Properties Pty Ltd has defeated a challenge brought by the Ku-ring-gai Council to its plans for development at the site of the former 3M building in a Sydney suburb.